Bridgefront Capital, LLC
- SEC CIK
- 0001725690
- Latest filing
- Aug 14, 2026
ABCL holding history
AbCellera Biologics Inc. in every 13F filed by Bridgefront Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABCL overviewAll 13F holders of ABCLFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −35,905−100.0% | Sold out | Holders |
| Q3 2023 | 35,905 | $165.2K | 0.1% | +13,314+58.9% | Added | Holders |
| Q2 2023 | 22,591 | $145.9K | 0.1% | −1,037−4.4% | Reduced | Holders |
| Q1 2023 | 23,628 | $178.2K | 0.1% | +9,858+71.6% | Added | Holders |
| Q4 2022 | 13,770 | $139.5K | 0.1% | +13,770 | New | Holders |